Literature DB >> 19907972

In vitro neural differentiation of human embryonic stem cells using a low-density mouse embryonic fibroblast feeder protocol.

John A Ozolek1, Esther P Jane, James E Esplen, Patti Petrosko, Amy K Wehn, Teresa M Erb, Sara E Mucko, Lyn C Cote, Paul J Sammak.   

Abstract

Human embryonic stem cells (hESCs) have the capacity to self-renew and to differentiate into all components of the embryonic germ layers (ectoderm, mesoderm, endoderm) and subsequently all cell types that comprise human tissues. HESCs can potentially provide an extraordinary source of cells for tissue engineering and great insight into early embryonic development. Much attention has been given to the possibility that hESCs and their derivatives may someday play major roles in the study of the development, disease therapeutics, and repair of injuries to the central and peripheral nervous systems. This tantalizing promise will be realized only when we understand fundamental biological questions about stem cell growth and development into distinct tissue types. In vitro, differentiation of hESCs into neurons proceeds as a multistep process that in many ways recapitulates development of embryonic neurons. We have found in vitro conditions that promote differentiation of stem cells into neuronal precursor or neuronal progenitor cells. Specifically, we have investigated the ability of two federally approved hESC lines, HSF-6 and H7, to form embryonic and mature neuronal cells in culture. Undifferentiated hESCs stain positively for markers of undifferentiated/pluripotent hESCs including surface glycoproteins, SSEA-3 and 4, and transcription factors Oct-3/4 and Nanog. Using reduced numbers of mouse embryonic fibroblasts as feeder substrates, these markers of pluripotency are lost quickly and replaced by primarily neuroglial phenotypes with only a few cells representing other embryonic germ layer types remaining. Within the first 2 weeks of co-culture with reduced MEFs, the undifferentiated hESCs show progression from neuroectodermal to neural stem cell to maturing and migrating neurons to mature neurons in a stepwise fashion that is dependent on both the type of hESCs and the density of MEFs. In this chapter, we provide the methods for culturing pluripotent hESCs and MEFs, differentiating hESCs using reduced density MEFs, and phenotypic analyses of this culture system.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19907972     DOI: 10.1007/978-1-60761-369-5_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  8 in total

1.  Paracrine and epigenetic control of trophectoderm differentiation from human embryonic stem cells: the role of bone morphogenic protein 4 and histone deacetylases.

Authors:  Teresa M Erb; Corinne Schneider; Sara E Mucko; Joseph S Sanfilippo; Nathan C Lowry; Mukund N Desai; Rami S Mangoubi; Sanford H Leuba; Paul J Sammak
Journal:  Stem Cells Dev       Date:  2011-03-17       Impact factor: 3.272

Review 2.  A review of the emerging potential therapy for neurological disorders: human embryonic stem cell therapy.

Authors:  Geeta Shroff; Jyoti Dhanda Titus; Rhea Shroff
Journal:  Am J Stem Cells       Date:  2017-04-15

Review 3.  Stem Cells for Temporomandibular Joint Repair and Regeneration.

Authors:  Shipin Zhang; Adrian U J Yap; Wei Seong Toh
Journal:  Stem Cell Rev Rep       Date:  2015-10       Impact factor: 5.739

4.  Medulloepithelioma with peculiar clinical presentation, stem cell phenotype and aberrant DNA-methylation profile.

Authors:  John A Ozolek; Debra E Cohen; Marcel Kool; Stefan M Pfister; Andrey Korshunov; Andrew J Bukowinski; Amy W Davis
Journal:  CNS Oncol       Date:  2015-06-29

5.  Human amniotic fluid stem cells support undifferentiated propagation and pluripotency of human embryonic stem cell without b-FGF in a density dependent manner.

Authors:  Xiaorong Ma; Huanqi Li; Shujia Xin; Yueting Ma; Tianxiang Ouyang
Journal:  Int J Clin Exp Pathol       Date:  2014-07-15

6.  Cryopreserved mouse fetal liver stromal cells treated with mitomycin C are able to support the growth of human embryonic stem cells.

Authors:  Wei Zhang; Jiabo Hu; Quanhui Ma; Sanqiang Hu; Yanyan Wang; Xiangmei Wen; Yongbin Ma; Hong Xu; Hui Qian; Wenrong Xu
Journal:  Exp Ther Med       Date:  2014-06-23       Impact factor: 2.447

7.  Differentiation renders susceptibility to excitotoxicity in HT22 neurons.

Authors:  Minchao He; Jun Liu; Shaowu Cheng; Yigang Xing; William Z Suo
Journal:  Neural Regen Res       Date:  2013-05-15       Impact factor: 5.135

Review 8.  A review on stem cell therapy for multiple sclerosis: special focus on human embryonic stem cells.

Authors:  Geeta Shroff
Journal:  Stem Cells Cloning       Date:  2018-02-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.